Market research
EMH.V Emerald Health Therapeutics, Inc
V CAD Healthcare
Latest close
Latest stored close unavailable
Test a moving-average rule with historical data.
Market facts
- Market cap
- 51M
- P/E ratio
- Not available
- Analyst target
- 0.4
- Dividend yield
- 0.0%
- Beta
- 1.07
Profile
Instrument facts
- Exchange
- V
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- CA29102R1064
- Market cap
- 51M
- P/E ratio
- Not available
- Analyst target
- 0.4
- Dividend yield
- 0.0%
- Beta
- 1.07
About
About Emerald Health Therapeutics, Inc
Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.
Research context
Emerald Health Therapeutics, Inc appears in PyInvesting’s TSX Venture Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the EMH.V discussion.
5 years, 6 months ago
Emerald Health Therapeutics, Inc is currently in a long term downtrend where the price is trading 0.3% below its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.1.
Emerald Health Therapeutics, Inc's total revenue sank by 63.7% to $3M since the same quarter in the previous year.
Its net income has increased by 33.4% to $-11M since the same quarter in the previous year.
Finally, its free cash flow grew by 96.2% to $-541K since the same quarter in the previous year.
Based on the above factors, Emerald Health Therapeutics, Inc gets an overall score of 3/5.